As of March 2024 Sumitomo Pharma has a market cap of $1.04 Billion. This makes Sumitomo Pharma the world's 5102th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.04 B | -20.4% |
2023 | $1.31 B | -55.76% |
2022 | $2.96 B | -35.13% |
2021 | $4.57 B | -22.03% |
2020 | $5.86 B | -24.51% |
2019 | $7.77 B | -38.24% |
2018 | $12.58 B | 113.6% |
2017 | $5.89 B | -14.21% |
2016 | $6.86 B | 45.51% |
2015 | $4.72 B | 21.2% |
2014 | $3.89 B | -37.47% |
2013 | $6.22 B | 30.2% |
2012 | $4.78 B | 6.62% |
2011 | $4.48 B | 24.68% |
2010 | $3.59 B | -13.78% |
2009 | $4.17 B | 14.42% |
2008 | $3.64 B | 25.25% |
2007 | $2.91 B | -37.08% |
2006 | $4.62 B |
On Mar 28th, 2024 the market cap of Sumitomo Pharma was reported to be: